Concepedia

Gerald L. DeNardo

GL

186

Publications

8.1K

Citations

51

H-Index

1966

Active since

Affiliations

University of California, Davis(Current)

University of California Davis Medical Center

Palmetto Hematology Oncology

Lawrence Livermore National Laboratory

University of California, San Francisco

Gerald L. DeNardo is an author at University of California, Davis specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

1966–2015

186

Publications

186

Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.

Sally J. DeNardo, Laird Miers, Kathleen R. Lamborn et al. · PubMed · 2002 · 213 citations

, , +17

Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy

Sally J. DeNardo, Gerald L. DeNardo, Laird Miers et al. · Clinical Cancer Research · 2005 · 197 citations

Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer

Robert Ivkov, Sally J. DeNardo, Wolfgang Daum et al. · Clinical Cancer Research · 2005 · 185 citations

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein et al. · Journal of Clinical Oncology · 1998 · 182 citations

Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.

S.V. Deshpande, Sally J. DeNardo, David L. Kukis et al. · PubMed · 1990 · 150 citations

, , +18

Rows per page

1–5 of 186